Editorial: Hybrids Part B: Hybrids for Drug Delivery
Front Bioeng Biotechnol
.
2021 Jun 30:9:720714.
doi: 10.3389/fbioe.2021.720714.
eCollection 2021.
Authors
Wei Li
1
,
Kai Zheng
2
,
Vilma Petrikaite
3
Affiliations
1
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
2
Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.
3
Laboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
PMID:
34277595
PMCID:
PMC8278281
DOI:
10.3389/fbioe.2021.720714
No abstract available
Keywords:
controlled release; drug delivery; hybrids; nanomedicines; nanoparticles.
Publication types
Editorial